Sung Ji Nam
Stock Analyst at Scotiabank
(3.59)
# 987
Out of 4,433 analysts
41
Total ratings
51.16%
Success rate
6.52%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintains: Sector Outperform | $43 → $48 | $47.01 | +2.11% | 3 | May 6, 2024 | |
| ILMN Illumina | Maintains: Sector Outperform | $185 → $176 | $111.07 | +58.46% | 5 | May 6, 2024 | |
| DMTK DermTech | Downgrades: Neutral | n/a | $0.50 | - | 2 | Apr 19, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Sector Outperform | $15 → $8 | $2.02 | +296.04% | 2 | Apr 18, 2024 | |
| BNGO Bionano Genomics | Maintains: Sector Outperform | $7 → $6 | $1.14 | +426.32% | 4 | Mar 7, 2024 | |
| CSTL Castle Biosciences | Maintains: Sector Outperform | $33 → $37 | $24.24 | +52.64% | 3 | Mar 1, 2024 | |
| OLK Olink Holding AB (publ) | Downgrades: Sector Perform | n/a | $23.95 | - | 3 | Oct 18, 2023 | |
| TKNO Alpha Teknova | Assumes: Buy | $6 | $1.79 | +235.20% | 2 | Jun 29, 2023 | |
| CDNA CareDx | Downgrades: Neutral | n/a | $15.50 | - | 2 | May 11, 2023 | |
| GH Guardant Health | Initiates: Sector Outperform | $36 | $25.36 | +41.96% | 2 | Jan 5, 2023 | |
| VCYT Veracyte | Initiates: Sector Outperform | $33 | $22.88 | +44.23% | 2 | Jan 5, 2023 | |
| ADPT Adaptive Biotechnologies | Initiates: Sector Outperform | $15 | $3.61 | +315.51% | 1 | Jan 5, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $718 | $595.30 | +20.61% | 8 | Feb 2, 2022 | |
| FLGT Fulgent Genetics | Downgrades: Neutral | n/a | $22.11 | - | 2 | Nov 24, 2020 |
Twist Bioscience
May 6, 2024
Maintains: Sector Outperform
Price Target: $43 → $48
Current: $47.01
Upside: +2.11%
Illumina
May 6, 2024
Maintains: Sector Outperform
Price Target: $185 → $176
Current: $111.07
Upside: +58.46%
DermTech
Apr 19, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.50
Upside: -
Pacific Biosciences of California
Apr 18, 2024
Maintains: Sector Outperform
Price Target: $15 → $8
Current: $2.02
Upside: +296.04%
Bionano Genomics
Mar 7, 2024
Maintains: Sector Outperform
Price Target: $7 → $6
Current: $1.14
Upside: +426.32%
Castle Biosciences
Mar 1, 2024
Maintains: Sector Outperform
Price Target: $33 → $37
Current: $24.24
Upside: +52.64%
Olink Holding AB (publ)
Oct 18, 2023
Downgrades: Sector Perform
Price Target: n/a
Current: $23.95
Upside: -
Alpha Teknova
Jun 29, 2023
Assumes: Buy
Price Target: $6
Current: $1.79
Upside: +235.20%
CareDx
May 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.50
Upside: -
Guardant Health
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $36
Current: $25.36
Upside: +41.96%
Veracyte
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $33
Current: $22.88
Upside: +44.23%
Adaptive Biotechnologies
Jan 5, 2023
Initiates: Sector Outperform
Price Target: $15
Current: $3.61
Upside: +315.51%
Thermo Fisher
Feb 2, 2022
Maintains: Buy
Price Target: $718
Current: $595.30
Upside: +20.61%
Fulgent Genetics
Nov 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $22.11
Upside: -